This is why the Pfizer and Moderna vaccines have to be so carefully preserved at ultra-low temperatures.
The vaccine triggers other parts of the immune system that keep an infection from getting out of control.
Killer T cells are shown attacking a virus-infected cell or tumor.
Further studies on dosages, or a specific vaccine for this variant, are in progress.
While more research is needed, there could be variations in immune responses from person to person based on such factors as age, medical conditions, and medications they may be taking.
With so many vaccines emerging in the market it has also become easier for health experts to evaluate their effectiveness.